Hudis CA - Search Results

1

Dose-dense therapy with weekly 1-hour paclitaxel infusions in the treatment of metastatic breast cancer.

Seidman AD, Hudis CA, Albanell J, Tong W, Tepler I, Currie V, Moynahan ME, Theodoulou M, Gollub M, Baselga J, Norton L. Seidman AD, et al. Among authors: hudis ca. J Clin Oncol. 1998 Oct;16(10):3353-61. doi: 10.1200/JCO.1998.16.10.3353. J Clin Oncol. 1998. PMID: 9779712 Review.

2

Memorial Sloan-Kettering Cancer Center experience with paclitaxel in the treatment of breast cancer.

Seidman AD, Hudis CA, Fennelly D, Raptis G, Baselga J, Norton L. Seidman AD, et al. Among authors: hudis ca. Semin Oncol. 1995 Oct;22(5 Suppl 12):108-16. Semin Oncol. 1995. PMID: 7481852 Review.

3

Taxol (paclitaxel) plus recombinant human granulocyte colony-stimulating factor in the treatment of metastatic breast cancer.

Seidman AD, Norton L, Reichman BS, Crown JP, Yao TJ, Hakes TB, Lebwohl DE, Gilewski TA, Hudis CA, Surbone A, et al. Seidman AD, et al. Among authors: hudis ca. Oncology. 1994 Oct;51 Suppl 1:33-9. doi: 10.1159/000227414. Oncology. 1994. PMID: 7526308 Clinical Trial.

4

Paclitaxel as second and subsequent therapy for metastatic breast cancer: activity independent of prior anthracycline response.

Seidman AD, Reichman BS, Crown JP, Yao TJ, Currie V, Hakes TB, Hudis CA, Gilewski TA, Baselga J, Forsythe P, et al. Seidman AD, et al. Among authors: hudis ca. J Clin Oncol. 1995 May;13(5):1152-9. doi: 10.1200/JCO.1995.13.5.1152. J Clin Oncol. 1995. PMID: 7537798 Clinical Trial.

5

Memorial Sloan-Kettering Cancer Center experience with paclitaxel in the treatment of breast cancer: from advanced disease to adjuvant therapy.

Seidman AD, Hudis CA, Norton L. Seidman AD, et al. Among authors: hudis ca. Semin Oncol. 1995 Aug;22(4 Suppl 8):3-8. Semin Oncol. 1995. PMID: 7543701 Clinical Trial.

6

Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer.

Reichman BS, Seidman AD, Crown JP, Heelan R, Hakes TB, Lebwohl DE, Gilewski TA, Surbone A, Currie V, Hudis CA, et al. Reichman BS, et al. Among authors: hudis ca. J Clin Oncol. 1993 Oct;11(10):1943-51. doi: 10.1200/JCO.1993.11.10.1943. J Clin Oncol. 1993. PMID: 7691998 Clinical Trial.

7

Systemic adjuvant therapy for breast cancer.

Hudis CA, Norton L. Hudis CA, et al. Curr Opin Oncol. 1993 Nov;5(6):982-90. doi: 10.1097/00001622-199311000-00006. Curr Opin Oncol. 1993. PMID: 8305548 Review.

8

Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer.

Hudis CA, Seidman AD, Crown JP, Balmaceda C, Freilich R, Gilewski TA, Hakes TB, Currie V, Lebwohl DE, Baselga J, Raptis G, Gollub M, Robles M, Bruno R, Norton L. Hudis CA, et al. J Clin Oncol. 1996 Jan;14(1):58-65. doi: 10.1200/JCO.1996.14.1.58. J Clin Oncol. 1996. PMID: 8558221 Clinical Trial.

9

Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer.

Baselga J, Tripathy D, Mendelsohn J, Baughman S, Benz CC, Dantis L, Sklarin NT, Seidman AD, Hudis CA, Moore J, Rosen PP, Twaddell T, Henderson IC, Norton L. Baselga J, et al. Among authors: hudis ca. J Clin Oncol. 1996 Mar;14(3):737-44. doi: 10.1200/JCO.1996.14.3.737. J Clin Oncol. 1996. PMID: 8622019 Clinical Trial.

10

Sequential adjuvant therapy with doxorubicin/paclitaxel/cyclophosphamide for resectable breast cancer involving four or more axillary nodes.

Hudis CA, Seidman AD, Baselga J, Raptis G, Lebwohl D, Gilewski T, Currie V, Moynahan ME, Sklarin N, Fennelly D, et al. Hudis CA, et al. Semin Oncol. 1995 Dec;22(6 Suppl 15):18-23. Semin Oncol. 1995. PMID: 8643965

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

307 results

Search Page

Filters